Skip to main content
. 2018 Jan;7(1):36–47. doi: 10.21037/tp.2017.08.02

Table 5. Cardiovascular screening history before starting pharmacotherapy.

Screening parameters Screening history
Symptoms* Unusual fatigue associated with physical activity (more than or different from others)
Pain, discomfort, or pressure in chest during exercise
Pre-syncope or syncope during or after exercise, emotion, or startle
Dizziness associated with exercise
Shortness of breath associated with exercise (more than or different from others)
Heart racing or skipped beats
Medical history and review of systems Unexplained seizures*
Detailed history of any congenital structural heart disease*
Use of cardiac pacemaker or implanted cardiac defibrillator*
History of Kawasaki disease*
History of rheumatic fever*—known heart murmur
Systemic hypertension
Substance abuse, tobacco use
Use of excessive caffeine or energy drinks
Any previous recommendations to restrict physical activity
Family history* Sudden or unexpected death of family members before age 50 years
Coronary artery disease before age 50 years
Family members using pacemaker or implanted cardiac defibrillator
Family history of cardiomyopathies, long QT syndrome, short QT syndrome, or Brugada syndrome
Family history of primary pulmonary hypertension

*, positive screening should warrant further cardiac evaluation.